Archive: 20/04/2017
Epilepsy drug behind up to 4,100 'severe birth defects' in France
The epilepsy medication valproate is responsible for "severe malformations" in 2,150 to 4,100 children in France since the drug was first marketed in the country in 1967, according to a preliminary study by French health ...
Apr 20, 2017
Studies examine rheumatoid arthritis patients' prognosis
What's the long-term outlook for today's patients with early rheumatoid arthritis? A new study in Arthritis & Rheumatology that looks at patients' mortality, disease activity, and physical function over the course of 20 years ...
Apr 20, 2017
Investing in adolescent health and education could bring 10-fold economic benefit
As the World Bank meetings begin, a new study shows that investments in adolescent health and wellbeing are some of the best that can be made towards achieving the SDGs.
Apr 20, 2017
Rituximab is not effective for the treatment of fatigue in primary biliary cholangitis
Results from the RITPBC trial demonstrated that rituximab was not effective for treatment of fatigue in unselected patients with primary biliary cholangitis (PBC). The study, presented at The International Liver Congress ...
Apr 20, 2017
Few Medicare patients take advantage of free annual wellness visits
In 2011, through the Affordable Care Act, Medicare introduced the Annual Wellness Visit (AWV), the first annual health check-up offered by Medicare at no cost to patients. The visits are intended to encourage evidence-based ...
Apr 20, 2017